imatinib sandoz 400 mg filmdragerad tablett
sandoz a/s - imatinibmesilat - filmdragerad tablett - 400 mg - imatinibmesilat 478 mg aktiv substans
imatinib sandoz 100 mg filmdragerad tablett
sandoz a/s - imatinibmesilat - filmdragerad tablett - 100 mg - imatinibmesilat 119,5 mg aktiv substans
imatinib stada 100 mg kapsel, hård
stada arzneimittel ag - imatinibmesilat - kapsel, hård - 100 mg - imatinibmesilat 119,5 mg aktiv substans; propylenglykol hjälpämne
imatinib stada 400 mg kapsel, hård
stada arzneimittel ag - imatinibmesilat - kapsel, hård - 400 mg - propylenglykol hjälpämne; imatinibmesilat 478 mg aktiv substans
imatinib stada 100 mg filmdragerad tablett
stada arzneimittel ag - imatinibmesilat - filmdragerad tablett - 100 mg - imatinibmesilat 119,47 mg aktiv substans
imatinib stada 400 mg filmdragerad tablett
stada arzneimittel ag - imatinibmesilat - filmdragerad tablett - 400 mg - imatinibmesilat 477,88 mg aktiv substans
darunavir teva 800 mg filmdragerad tablett
teva sweden ab - darunavir - filmdragerad tablett - 800 mg - darunavir 800 mg aktiv substans
nexpovio
stemline therapeutics b.v. - selinexor - multipelt myelom - antineoplastiska medel - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
levetiracetam 1a farma 500 mg filmdragerad tablett
uab bijon medica - levetiracetam - filmdragerad tablett - 500 mg - levetiracetam 500 mg aktiv substans
levetiracetam 1a farma 250 mg filmdragerad tablett
uab bijon medica - levetiracetam - filmdragerad tablett - 250 mg - levetiracetam 250 mg aktiv substans